Brazilian Health Minister Alexandre Padilha has described President Luiz Inacio Lula da Silva's recent visit to India as "historic", calling it a watershed moment in bilateral relations with significant implications for Brazil's pharmaceutical sector and public health system.
Gurugram (Haryana) [India], February 23: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major.
The domestic healthcare sector is expected to see stronger growth over the next three years supported by new drug launches, while earnings from the US generics business are likely to remain flat for most companies, according to a report by Systematix Research.
Brazilian President Luiz Inacio Lula da Silva praised the Brazil-India partnership as one of equals, highlighting shared priorities and growing trade. He expressed confidence that bilateral trade could exceed targets. India and Brazil also strengthened cooperation in pharmaceutical and medic
India and Brazil exchanged a Memorandum of Understanding (MoU) to strengthen bilateral cooperation in the field of regulation of pharmaceutical and medical products.
The interaction served as a structured platform for aligning regulatory frameworks, export policies, and industry capabilities with the evolving requirements of global pharmaceutical markets.
A Fire Official on the day of the incident said, "An explosion occurred at Vijaysai Pharma chemical industry while chemicals were being mixed, likely due to a short circuit. One employee, Pawan Kumar, aged 35, died on the spot.
Hyderabad (Telangana) [India], February 20: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's leading integrated contract research, development and manufacturing organizations (CRDMOs), today announced plans to hire 700+ scientific, technical, and management professional
Hyderabad (Telangana) [India], February 20: GV Research Platform (GVRP) today announced a strategic distribution partnership with Yurogen Biosystems, a global life sciences company specialising in custom biologics development. The collaboration is aimed at expanding access for Indian biotech
New Delhi [India], February 19: Boehringer Ingelheim India Private Limited today announced the signing of a Memorandum of Understanding (MoU) with the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, including its Centre of Excellence for Novel Drug Delivery Sy
The initiative comes days after the launch of the Brazilian Association of the Indian Pharmaceutical Industry in Brasilia, intended to act as an institutional bridge between Indian drugmakers and the Brazilian market by facilitating partnerships, investments and regulatory compliance.
AIOCD President J S Shinde and General Secretary Rajiv Singhal informed that in a recent media investigation, including reports in a renowned newspaper, which have revealed that AI-generated prescriptions with fabricated hospital details are being accepted by certain online platforms.